Natural Health Products Regulations – Overview and Guidance for Canadian Market Entry

Navigating the complex and ever-evolving landscape of Natural Health Products Regulations (NHPR) in Canada is crucial for businesses hoping to enter the Canadian market. Canada offers a significant market opportunity for companies, similar to the U.S., but success depends on a thorough understanding of the regulatory requirements. Ensuring compliance with these regulations is essential not only for market entry but also for building long-term consumer trust.

At the heart of this process is understanding both product and site licensing for NHPs, which are critical for compliance and smooth market integration. Canada’s regulations emphasize safety and product quality, ensuring that consumers have access to reliable, effective health products. For businesses, these regulations provide clear, well-established standards and processes, simplifying market entry and helping them save valuable time and resources while building strong consumer confidence.

Natural Health Products (NHPs) and Their Regulations

What Are Natural Health Products (NHPs)?

Natural Health Products (NHPs) are substances used to support health and well-being, typically derived from natural sources such as plants, animals, or marine materials. They appear in many forms, including tablets, capsules, creams, liquids, and drops, and are intended for a wide range of purposes. These can include managing specific conditions, supporting general wellness, or contributing to daily self-care. Common examples include vitamins, minerals, herbal remedies, probiotics, as well as certain everyday items like toothpastes, shampoos, sunscreens, and other skincare products that meet the criteria for NHPs.

According to Natural Health Products Regulations:

“natural health product means a substance set out in Schedule 1 or a combination of substances in which all the medicinal ingredients are substances set out in Schedule 1, a homeopathic medicine or a traditional medicine, that is manufactured, sold or represented for use in:

However, a natural health product does not include a substance set out in Schedule 2, any combination of substances that includes a substance set out in Schedule 2 or a homeopathic medicine or a traditional medicine that is or includes a substance set out in Schedule 2.”

What Are Natural Health Products (NHP) Regulations?

In Canada, NHPs are governed by the Natural Health Products Regulations (NHPR) under the Food and Drugs Act. These regulations apply to products containing medicinal ingredients listed in Schedule 1, excluding any substances listed in Schedule 2. They cover a range of self care products such as vitamins, minerals, herbal remedies, probiotics, and certain topical preparations that do not require practitioner supervision.

The NHPR establish the legal requirements for product licensing, site licensing, Good Manufacturing Practices (GMP), labelling, and post market obligations for NHPs. Every product must obtain a licence in the form of an NPN or DIN HM, supported by evidence that demonstrates the safety, efficacy, quality, dose, and recommended conditions of use. Facilities that manufacture, package, label, or import NHPs must hold a site licence and comply with GMP standards specific to these products.

Unlike prescription and non prescription drugs regulated under the Food and Drug Regulations, NHPs follow a risk appropriate framework designed for naturally derived products intended for self selection. This ensures that NHPs meet defined safety and evidence requirements while maintaining a regulatory pathway proportionate to their intended use and lower risk profile.

Purpose of the Natural Health Products (NHP) Regulations

The goal of NHP regulations in Canada is to create a transparent, safe, and effective market for natural health products. These regulations establish clear licensing requirements and labelling standards, ensuring that consumers can make informed decisions based on essential product information like ingredients, dosage, and potential side effects. Additionally, the regulations safeguard consumers from misleading claims and ensure that any health-related statements are supported by credible scientific evidence or traditional usage

NHP regulations also require that products meet stringent quality standards to prevent contamination and minimize the risk of adverse effects. These measures create a trustworthy environment for consumers while holding manufacturers accountable for their product claims. Ultimately, these regulations aim to protect public health and maintain the integrity of the natural health product market in Canada.

Key Components of NHP Regulations

Health Canada plays a pivotal role in overseeing the safety and quality of natural health products (NHPs). For businesses, understanding the following key regulatory components is essential:

1. Site Licensing
2. Product Licensing
3. Product Labelling
4. Post-market Surveillance

Natural Health Product (NHP) Licensing

Product licensing is a critical step in the NHP regulatory pathway, requiring each product to undergo review by Health Canada’s NNHPD. During this assessment, Health Canada evaluates the product’s safety, efficacy, and quality based on the evidence provided, along with the proposed medicinal ingredients, dose, format, and recommended conditions of use.

To meet these requirements, manufacturers must follow GMP that ensure product consistency and prevent contamination. For instance, a company producing fish oil supplements must implement controls for oxidation, verify the purity of raw oils, conduct appropriate microbial and heavy metal testing, and maintain detailed records throughout production, packaging, and labelling. These GMP measures demonstrate that the product is manufactured safely and meets the quality standards required under the NHPR.

Natural Health Product (NHP) Labelling Requirements

Compliant labelling ensures that consumers have clear and accurate product information, including health claims, dosage instructions, and any potential risks. Labels must align with Health Canada’s guidelines, and NHPs can only make claims that have been approved through the product licensing process. Labelling in Canada must meet bilingual requirements, with information provided in both English and French. Compliant labelling is essential to ensure consumer transparency and build trust. Adhering to all labelling standards and requirements should be a top priority when preparing products for the Canadian market, as it plays a crucial role in regulatory compliance and consumer confidence.

Natural Health Product (NHP) Post-market Surveillance

Post market surveillance is another key element of the NHP framework. Once an NHP is licensed and available for sale, Health Canada continues to monitor its safety, quality, and compliance through activities such as inspections, product sampling, and the review of consumer and industry complaints. Companies are legally required to maintain distribution records, respond to information requests, and implement corrective actions where necessary. This oversight helps ensure that products continue to meet the standards set out in the NHPR long after their initial approval.

A core requirement under the NHPR is mandatory adverse reaction reporting. Manufacturers, importers, and distributors must report serious adverse reactions to Health Canada within defined timelines and maintain detailed records for at least seven years. These reports are analyzed by Health Canada’s Marketed Health Products Directorate, which monitors trends, identifies potential safety signals, and determines whether further regulatory action is needed.

When issues are identified, Health Canada can take a range of compliance and enforcement actions, including requesting label changes, suspending or cancelling product licences, issuing public advisories, and conducting product recalls. These measures ensure that NHPs remain safe, accurately represented, and compliant with Canadian requirements throughout their entire life cycle.

Natural Health Product (NHP) Licensing in Canada

Before any NHP can be sold in Canada, it must obtain a Natural Product Number (NPN) by submitting a Product License Application (PLA) to Health Canada. The PLA includes detailed information to demonstrate the product’s safety, efficacy, and quality, and the application class varies depending on the product’s risk level. Understanding the appropriate class for your product and providing the necessary documentation is crucial for a successful application.

Three Core Steps of Natural Health Product (NHP) Licensing

1. Complete the PLA: Submit the application with comprehensive product information.
2. Health Canada’s Review: Health Canada evaluates the safety, efficacy, and quality of the product.
3. Approval and NPN Issuance: If approved, the product is granted an NPN and can be marketed in Canada.

The time for approval varies depending on the product class, ranging from Class I (lowest risk) to Class III (highest risk). Proper documentation and a clear understanding of product-specific regulations can help shorten the approval process.

One of the challenges manufacturers face during this process is dealing with lengthy review times and the possibility of receiving Information Request Notices (IRNs), which may ask for additional details to continue the review. Incomplete applications can be rejected, so working with regulatory experts can help avoid delays and ensure the completeness of an application package.

Application Requirements for Natural Health Products (NHPs) in Canada

To legally market a NHP in Canada, manufacturers must submit a complete PLA to Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD). This application must provide robust evidence to demonstrate the safety, efficacy, and quality of the product, in line with the Natural Health Products Regulations.

Key Documentation Requirements for a Product Licence Application (PLA)

Ingredient Specifications and Testing Results for the Natural Health Product (NHP)

In addition to submitting an ePLA, applicants must submit detailed specifications for each medicinal ingredient, including the botanical or chemical source, standardization parameters (if applicable), and analytical testing results confirming the identity, purity, potency, and stability of the ingredients.

Additionally, Finished Product Specifications (FPS) must be provided. These outline the criteria and acceptable limits for microbial contaminants, heavy metals, and other potential impurities, and must reflect the product’s dosage form and route of administration. The FPS ensures the final product consistently meets quality standards throughout its shelf life.

Bilingual Labelling and Dosage Instructions

The PLA must include label text in both English and French, compliant with Health Canada’s labelling requirements under the Consumer Packaging and Labelling Act and NHP Regulations. This includes:

All information must be clear, accurate, and based on evidence to ensure the product is used safely and effectively.

Supporting Evidence for Natural Health Product (NHP) Safety and Efficacy

If the product’s medicinal ingredients and intended use are covered by an existing Health Canada monograph, the PLA can follow an attestation-based route, simplifying the review process.

However, if ingredients, claims, or dosages fall outside monograph parameters, applicants must submit comprehensive supporting evidence, such as:

This evidence must be robust and comprehensive enough to demonstrate the safety of each medicinal ingredient at the proposed dose and to substantiate all intended health claims. Health Canada relies heavily on this data when assessing PLAs. If the supporting information does not sufficiently validate the safety or efficacy of the ingredients or the product as a whole, the PLA may rejected, resulting in additional review time and potential reformulation or claim adjustments.

Benefits of Complying with Natural Health Products (NHP) Regulations

Compliance with NHPR in Canada offers significant advantages for brands looking to build trust, reduce risk, and expand into new markets. Meeting Health Canada’s standards for licensing, evidence, GMP, and labelling positions companies for long term success and sustained consumer confidence. Below are the three primary benefits of maintaining strong NHP regulatory compliance.

Stronger Consumer Trust Through Verified Safety and Efficacy

Compliance ensures that products meet Health Canada’s evidence based requirements for safety, efficacy, and quality. When consumers see an NPN on a product and understand that it has passed a formal pre market review, it enhances their confidence in the brand. This trust supports long term customer loyalty and helps establish a stable market presence.

Competitive Advantage and Reduced Legal and Regulatory Risk

Companies that consistently meet regulatory requirements are viewed as more credible, reliable, and professional. This reputational advantage can translate into higher sales and improved retailer relationships. In addition, compliance protects businesses from enforcement actions, fines, recalls, and penalties, reducing operational disruptions and preserving brand reputation.

Enhanced Opportunities for International Market Expansion

Securing an NPN and meeting Canadian regulatory standards can support global growth. Many international regulators view Canada’s NHP framework as rigorous, and products already licensed in Canada may move more smoothly through other regulatory systems. For companies looking to enter markets such as the United States, Europe, or Asia, Canadian compliance can be a strong selling point and may streamline the approval or assessment process.

Consequences of Non-Compliance with NHP Regulations

Non compliance with Natural Health Products Regulations in Canada can lead to serious regulatory, financial, and operational consequences. Health Canada actively monitors the NHP market, and companies that fail to meet requirements for licensing, GMP, labelling, or evidence may face significant penalties. Below are the three most common outcomes associated with Health Canada NHP compliance failures:

Product Recalls, Stop Sale Orders, and Suspension of NPN Licences

One of the most frequent consequences of NHP non compliance is the removal of products from the Canadian market. Health Canada may issue stop sale orders, mandate recalls, or suspend or cancel an NPN if the product is unsafe, inadequately supported by evidence, improperly labelled, or manufactured outside GMP standards. These actions result in immediate loss of market access and can trigger broader reviews of a company’s full product line.

Health Canada Enforcement Actions, Inspection Findings, and Financial Penalties

During inspections or compliance verifications, Health Canada may seize product, issue warning letters, require corrective action plans, or apply fines. Common causes include selling unlicensed NHPs, incomplete adverse reaction reporting, inadequate manufacturing controls, or unsupported claims. Companies may also be flagged for enhanced monitoring, which increases regulatory scrutiny and can delay future product submissions.

Reputational Damage, Loss of Retailer Confidence, and Business Disruption

Health Canada publishes recalls, advisories, and enforcement actions on public channels, which can harm brand credibility and reduce consumer trust. Retailers often remove non compliant products from shelves, creating further financial losses. Operational impacts may include halted production, relabelling, retesting, or reformulation, all of which carry additional cost and delay.

Maintaining compliance with Health Canada’s Natural Health Products Regulations not only protects consumer safety but also helps businesses safeguard market access, avoid costly enforcement actions, and strengthen long term brand trust.

Final Remarks

Navigating the regulatory landscape for NHPs in Canada can be straightforward with the right guidance. By following the required steps for supplement licensing, obtaining an NPN, and adhering to the necessary documentation and standards, businesses can successfully enter the Canadian market. Compliance not only prevents legal challenges but also builds consumer confidence, helping businesses establish themselves as trustworthy, reliable brands. With the right preparation, your products can thrive in the Canadian marketplace and beyond.

Comprehensive Regulatory Support for Natural Health Products (NHPs) in Canada

Looking to bring your NHP to the Canadian market? SNI provides comprehensive regulatory consulting to guide you through every step of the process. Our team supports NHP and site licensing, labelling compliance, quality assurance reviews, importation pathways, and clinical studies to strengthen your evidence package. Whether you require a straightforward NPN application or a more advanced strategy to support complex health claims, we deliver the expertise and support needed for a smooth and compliant launch.

💊 More about our services here.
💡 Compliance is easy with the right support! 
📩 info@sourcenutra.com

⬇️ Send us a request for support or an introductory call

FAQ

What qualifies as a Natural Health Product (NHP) in Canada?

Natural Health Products (NHPs) include a wide range of substances used to maintain or improve health. These products can be derived from natural sources such as plants, animals, or marine life, and may include vitamins, minerals, herbal remedies, homeopathic and traditional medicines, probiotics, amino acids, and essential fatty acids. NHPs are intended for therapeutic use and are distinct from both prescription drugs and conventional foods. To be classified as an NHP, the product must meet specific criteria outlined in Canada’s Natural Health Products Regulations, which ensures they are safe for self-care and suitable for over-the-counter use.

Why are NHPs regulated differently from food and pharmaceutical drugs?

NHPs are regulated as their own category because they do not fit neatly into the existing frameworks for either foods or pharmaceutical drugs. While they are marketed for health benefits, they typically do not require a prescription and have a different risk profile than conventional medicines. Regulating NHPs separately allows Health Canada to enforce appropriate safety, efficacy, and labelling standards that reflect the nature of these products. This ensures consumers can access them safely while still being protected from misleading claims or substandard manufacturing practices.

What licences are required to manufacture, import, or sell NHPs in Canada?

To legally manufacture, package, label, or import NHPs for sale in Canada, businesses must obtain two key licences. First, a site licence is required for any Canadian facility involved in these activities, ensuring the site meets Good Manufacturing Practices (GMPs). Second, each individual product must have its own product licence, issued by Health Canada, which is identified by a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM). These licences confirm that the product has been reviewed and approved based on its safety, efficacy, and quality.

What documentation is needed to obtain a Natural Product Number (NPN)?

To receive an NPN, applicants must submit a comprehensive Product Licence Application (PLA) to Health Canada. This includes detailed specifications for each medicinal ingredient, supporting analytical testing results, and Finished Product Specifications (FPS) that demonstrate the product’s identity, purity, and potency. The PLA must also include bilingual labelling information – such as recommended use, dosage, warnings, and contraindications – in both English and French. If the product does not align with an existing monograph, additional evidence such as clinical studies, published literature, or traditional use data must be included to support the proposed health claims and dosage levels.

What happens if an NHP does not comply with Canadian regulations after entering the market?

Non-compliance with NHP regulations can lead to serious consequences for businesses. Health Canada may take corrective actions such as issuing warnings, mandating product recalls, suspending or cancelling licences, or imposing financial penalties. In some cases, products may be removed from the market altogether, especially if they are deemed unsafe or misleading. Beyond regulatory enforcement, non-compliance can also damage a company’s brand reputation and erode consumer trust. To avoid these outcomes, it is critical for businesses to maintain ongoing compliance through proper labelling, manufacturing, and post-market surveillance.

---

✷ The content on this website, including information presented in this post, is provided for general informational purposes only and does not constitute legal, regulatory, or professional advice. While efforts are made to ensure accuracy, laws and regulations vary by jurisdiction and may change over time. Readers should not rely on this information as a substitute for advice from qualified legal or regulatory professionals. We disclaim any liability for actions taken based on this content, and users are encouraged to seek guidance specific to their circumstances.